ST交昂(600530) - 2024 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2024 was ¥76,883,704.44, representing a year-on-year increase of 13.81%[3]. - The net profit attributable to shareholders for the same period was ¥3,499,909.74, with a year-to-date net profit of ¥6,737,418.17, showing a decrease of 5.47% compared to the previous year[3]. - Total operating revenue for the first three quarters of 2024 was CNY 236,896,509.26, a decrease of 5.1% compared to CNY 250,616,807.08 in the same period of 2023[15]. - Net profit for the third quarter of 2024 was CNY 10,128,115.03, a significant recovery from a net loss of CNY 25,502,918.99 in the same quarter of 2023[16]. - The company reported a basic earnings per share of CNY 0.01, compared to a loss per share of CNY 0.04 in the previous year[17]. Cash Flow - The net cash flow from operating activities for the year-to-date period decreased by 79.17%, amounting to ¥8,612,892.47[3][7]. - The company reported a significant decrease in cash flow from operating activities due to new loans issued in the investment and financing sector[7]. - The cash flow from operating activities showed improvement, contributing positively to the overall financial health of the company[17]. - In the first three quarters of 2024, the cash inflow from operating activities totaled ¥266,012,909.39, a decrease of 10.9% compared to ¥298,704,800.16 in the same period of 2023[18]. - The net cash flow from operating activities for the third quarter of 2024 was ¥8,612,892.47, significantly lower than ¥41,347,820.75 in the third quarter of 2023[19]. Assets and Liabilities - Total assets at the end of the reporting period were ¥757,799,073.56, down 7.03% from the previous year-end[4]. - The company's current assets totaled RMB 205,950,622.37, down from RMB 271,751,287.50, indicating a decrease of about 24.2%[12]. - The total liabilities decreased to CNY 408,491,686.75 from CNY 475,915,787.16, a reduction of approximately 14.1%[14]. - The company's total equity increased to CNY 349,307,386.81 from CNY 339,179,271.78, reflecting a growth of 3.3%[14]. Investments and Expenses - Research and development expenses decreased to CNY 3,627,801.95 from CNY 7,414,003.31, indicating a reduction of 51%[15]. - The company reported a significant increase in investment income to CNY 4,142,266.16 from a loss of CNY 924,353.35 in the previous year[16]. - The company reported a significant increase in long-term equity investments, rising to RMB 44,448,741.95 from RMB 40,403,103.95, which is an increase of approximately 10.1%[12]. Shareholder Information - The company has no significant changes in the top 10 shareholders or their participation in margin trading compared to the previous period[10]. - The company has not disclosed any new strategies or product developments during this reporting period[10]. Operational Highlights - There are no significant reminders or additional important information regarding the company's operational status during the reporting period[11]. - The company has not identified any new non-recurring gains or losses beyond those listed in the regulatory announcement[7].